APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nitinol Revascularization Device

Compare research editions
View pricing & licenses

Selected research

Industry Research

Nitinol Revascularization Device Industry Research Report 2026

26 December 2025133 pages

Choose your research edition.

Industry ResearchNitinol Revascularization Device Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Nitinol Revascularization Device Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Nitinol Revascularization Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nitinol Revascularization Device Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Nitinol Revascularization Device Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Nitinol Revascularization Device market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Nitinol Revascularization Device is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Nitinol Revascularization Device is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Nitinol Revascularization Device is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Nitinol Revascularization Device include Acandis GmbH, Balt Group, Furukawa Techno Material, Johnson & Johnson MedTech, Penumbra, Rapid Medical, Stryker, Guichuangtongqiao Medical and Hemu Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Nitinol Revascularization Device market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Nitinol Revascularization Device Market by Company

Acandis GmbH

Balt Group

Furukawa Techno Material

Johnson & Johnson MedTech

Penumbra

Rapid Medical

Stryker

Guichuangtongqiao Medical

Hemu Biotech

Jianshi Medical

Medtronic

Sinoshenchang Medical

Suzhou Zhongtian Medical

Micro-Port Shentong Medical

Xinkainuo Medical

Xinwei Medical

Nitinol Revascularization Device Segment by Type

Diameter 6MM

Diameter 4MM

Diameter 3MM

Other

Nitinol Revascularization Device Segment by Application

Hospital

Clinic

Other

Nitinol Revascularization Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitinol Revascularization Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nitinol Revascularization Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitinol Revascularization Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Nitinol Revascularization Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Nitinol Revascularization Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Nitinol Revascularization Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nitinol Revascularization Device Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Nitinol Revascularization Device Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Nitinol Revascularization Device Sales Market Share by Manufacturers (2021-2026) Table 8. Global Nitinol Revascularization Device Revenue of Manufacturers (2021-2026) Table 9. Global Nitinol Revascularization Device Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Nitinol Revascularization Device Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Nitinol Revascularization Device Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Nitinol Revascularization Device, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Nitinol Revascularization Device, Product Type & Application Table 14. Global Nitinol Revascularization Device Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Nitinol Revascularization Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Acandis GmbH Company Information Table 19. Acandis GmbH Business Overview Table 20. Acandis GmbH Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Acandis GmbH Nitinol Revascularization Device Product Portfolio Table 22. Acandis GmbH Recent Developments Table 23. Balt Group Company Information Table 24. Balt Group Business Overview Table 25. Balt Group Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Balt Group Nitinol Revascularization Device Product Portfolio Table 27. Balt Group Recent Developments Table 28. Furukawa Techno Material Company Information Table 29. Furukawa Techno Material Business Overview Table 30. Furukawa Techno Material Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Furukawa Techno Material Nitinol Revascularization Device Product Portfolio Table 32. Furukawa Techno Material Recent Developments Table 33. Johnson & Johnson MedTech Company Information Table 34. Johnson & Johnson MedTech Business Overview Table 35. Johnson & Johnson MedTech Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Johnson & Johnson MedTech Nitinol Revascularization Device Product Portfolio Table 37. Johnson & Johnson MedTech Recent Developments Table 38. Penumbra Company Information Table 39. Penumbra Business Overview Table 40. Penumbra Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Penumbra Nitinol Revascularization Device Product Portfolio Table 42. Penumbra Recent Developments Table 43. Rapid Medical Company Information Table 44. Rapid Medical Business Overview Table 45. Rapid Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Rapid Medical Nitinol Revascularization Device Product Portfolio Table 47. Rapid Medical Recent Developments Table 48. Stryker Company Information Table 49. Stryker Business Overview Table 50. Stryker Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Stryker Nitinol Revascularization Device Product Portfolio Table 52. Stryker Recent Developments Table 53. Guichuangtongqiao Medical Company Information Table 54. Guichuangtongqiao Medical Business Overview Table 55. Guichuangtongqiao Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Guichuangtongqiao Medical Nitinol Revascularization Device Product Portfolio Table 57. Guichuangtongqiao Medical Recent Developments Table 58. Hemu Biotech Company Information Table 59. Hemu Biotech Business Overview Table 60. Hemu Biotech Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Hemu Biotech Nitinol Revascularization Device Product Portfolio Table 62. Hemu Biotech Recent Developments Table 63. Jianshi Medical Company Information Table 64. Jianshi Medical Business Overview Table 65. Jianshi Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Jianshi Medical Nitinol Revascularization Device Product Portfolio Table 67. Jianshi Medical Recent Developments Table 68. Medtronic Company Information Table 69. Medtronic Business Overview Table 70. Medtronic Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Medtronic Nitinol Revascularization Device Product Portfolio Table 72. Medtronic Recent Developments Table 73. Sinoshenchang Medical Company Information Table 74. Sinoshenchang Medical Business Overview Table 75. Sinoshenchang Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sinoshenchang Medical Nitinol Revascularization Device Product Portfolio Table 77. Sinoshenchang Medical Recent Developments Table 78. Suzhou Zhongtian Medical Company Information Table 79. Suzhou Zhongtian Medical Business Overview Table 80. Suzhou Zhongtian Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Suzhou Zhongtian Medical Nitinol Revascularization Device Product Portfolio Table 82. Suzhou Zhongtian Medical Recent Developments Table 83. Micro-Port Shentong Medical Company Information Table 84. Micro-Port Shentong Medical Business Overview Table 85. Micro-Port Shentong Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Micro-Port Shentong Medical Nitinol Revascularization Device Product Portfolio Table 87. Micro-Port Shentong Medical Recent Developments Table 88. Xinkainuo Medical Company Information Table 89. Xinkainuo Medical Business Overview Table 90. Xinkainuo Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Xinkainuo Medical Nitinol Revascularization Device Product Portfolio Table 92. Xinkainuo Medical Recent Developments Table 93. Xinwei Medical Company Information Table 94. Xinwei Medical Business Overview Table 95. Xinwei Medical Nitinol Revascularization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Xinwei Medical Nitinol Revascularization Device Product Portfolio Table 97. Xinwei Medical Recent Developments Table 98. Global Nitinol Revascularization Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Nitinol Revascularization Device Sales by Region (2021-2026) & (K Units) Table 100. Global Nitinol Revascularization Device Sales Market Share by Region (2021-2026) Table 101. Global Nitinol Revascularization Device Sales by Region (2027-2032) & (K Units) Table 102. Global Nitinol Revascularization Device Sales Market Share by Region (2027-2032) Table 103. Global Nitinol Revascularization Device Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Nitinol Revascularization Device Revenue Market Share by Region (2021-2026) Table 105. Global Nitinol Revascularization Device Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Nitinol Revascularization Device Revenue Market Share by Region (2027-2032) Table 107. North America Nitinol Revascularization Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 109. North America Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 110. North America Nitinol Revascularization Device Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Nitinol Revascularization Device Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Nitinol Revascularization Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 114. Europe Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 115. Europe Nitinol Revascularization Device Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Nitinol Revascularization Device Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Nitinol Revascularization Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 119. Asia Pacific Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 120. Asia Pacific Nitinol Revascularization Device Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Nitinol Revascularization Device Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Nitinol Revascularization Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 124. South America Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 125. South America Nitinol Revascularization Device Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Nitinol Revascularization Device Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Nitinol Revascularization Device Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Nitinol Revascularization Device Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Nitinol Revascularization Device Sales by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Nitinol Revascularization Device Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Nitinol Revascularization Device Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Nitinol Revascularization Device Sales by Type (2021-2026) & (K Units) Table 133. Global Nitinol Revascularization Device Sales by Type (2027-2032) & (K Units) Table 134. Global Nitinol Revascularization Device Sales Market Share by Type (2021-2026) Table 135. Global Nitinol Revascularization Device Sales Market Share by Type (2027-2032) Table 136. Global Nitinol Revascularization Device Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Nitinol Revascularization Device Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Nitinol Revascularization Device Revenue Market Share by Type (2021-2026) Table 139. Global Nitinol Revascularization Device Revenue Market Share by Type (2027-2032) Table 140. Global Nitinol Revascularization Device Price by Type (2021-2026) & (US$/Unit) Table 141. Global Nitinol Revascularization Device Price by Type (2027-2032) & (US$/Unit) Table 142. Global Nitinol Revascularization Device Sales by Application (2021-2026) & (K Units) Table 143. Global Nitinol Revascularization Device Sales by Application (2027-2032) & (K Units) Table 144. Global Nitinol Revascularization Device Sales Market Share by Application (2021-2026) Table 145. Global Nitinol Revascularization Device Sales Market Share by Application (2027-2032) Table 146. Global Nitinol Revascularization Device Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Nitinol Revascularization Device Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Nitinol Revascularization Device Revenue Market Share by Application (2021-2026) Table 149. Global Nitinol Revascularization Device Revenue Market Share by Application (2027-2032) Table 150. Global Nitinol Revascularization Device Price by Application (2021-2026) & (US$/Unit) Table 151. Global Nitinol Revascularization Device Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Nitinol Revascularization Device Distributors List Table 155. Nitinol Revascularization Device Customers List Table 156. Nitinol Revascularization Device Industry Trends Table 157. Nitinol Revascularization Device Industry Drivers Table 158. Nitinol Revascularization Device Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Nitinol Revascularization Device Product Image Figure 5. Global Nitinol Revascularization Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Nitinol Revascularization Device Market Size (2021-2032) & (US$ Million) Figure 7. Global Nitinol Revascularization Device Sales (2021-2032) & (K Units) Figure 8. Global Nitinol Revascularization Device Average Price (US$/Unit) & (2021-2032) Figure 9. Diameter 6MM Product Image Figure 10. Diameter 4MM Product Image Figure 11. Diameter 3MM Product Image Figure 12. Other Product Image Figure 13. Hospital Product Image Figure 14. Clinic Product Image Figure 15. Other Product Image Figure 16. Global Nitinol Revascularization Device Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Nitinol Revascularization Device, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Nitinol Revascularization Device Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Nitinol Revascularization Device Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Nitinol Revascularization Device Sales by Region in 2025 Figure 22. Global Nitinol Revascularization Device Revenue by Region in 2025 Figure 23. North America Nitinol Revascularization Device Market Size by Country in 2025 Figure 24. North America Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 25. North America Nitinol Revascularization Device Revenue Market Share by Country (2021-2032) Figure 26. United States Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Nitinol Revascularization Device Market Size by Country in 2025 Figure 30. Europe Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 31. Europe Nitinol Revascularization Device Revenue Market Share by Country (2021-2032) Figure 32. Germany Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Nitinol Revascularization Device Market Size by Country in 2025 Figure 43. Asia Pacific Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Nitinol Revascularization Device Revenue Market Share by Country (2021-2032) Figure 45. China Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Nitinol Revascularization Device Market Size by Country in 2025 Figure 54. South America Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 55. South America Nitinol Revascularization Device Revenue Market Share by Country (2021-2032) Figure 56. Brazil Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Nitinol Revascularization Device Market Size by Country in 2025 Figure 60. Middle East and Africa Nitinol Revascularization Device Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Nitinol Revascularization Device Revenue Market Share by Country (2021-2032) Figure 62. Egypt Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Nitinol Revascularization Device Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Nitinol Revascularization Device Sales Market Share by Type (2021-2032) Figure 68. Global Nitinol Revascularization Device Revenue Market Share by Type (2021-2032) Figure 69. Global Nitinol Revascularization Device Price (US$/Unit) by Type (2021-2032) Figure 70. Global Nitinol Revascularization Device Sales Market Share by Application (2021-2032) Figure 71. Global Nitinol Revascularization Device Revenue Market Share by Application (2021-2032) Figure 72. Global Nitinol Revascularization Device Price (US$/Unit) by Application (2021-2032) Figure 73. Nitinol Revascularization Device Value Chain Figure 74. Nitinol Revascularization Device Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Nitinol Revascularization Device Industry Opportunities and Challenges

Scope & coverage.

Types
  • Diameter 6MM
  • Diameter 4MM
  • Diameter 3MM
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Acandis GmbH
  • Balt Group
  • Furukawa Techno Material
  • Johnson & Johnson MedTech
  • Penumbra
  • Rapid Medical
  • Stryker
  • Guichuangtongqiao Medical
  • Hemu Biotech
  • Jianshi Medical
  • Medtronic
  • Sinoshenchang Medical
  • Suzhou Zhongtian Medical
  • Micro-Port Shentong Medical
  • Xinkainuo Medical
  • Xinwei Medical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Nitinol Revascularization Device Market Size (2021-2032)
  4. 2.2.2 Global Nitinol Revascularization Device Sales (2021-2032)
  5. 2.2.3 Global Nitinol Revascularization Device Market Average Price (2021-2032)
  6. 2.3 Nitinol Revascularization Device by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Diameter 6MM
  9. 2.3.3 Diameter 4MM
  10. 2.3.4 Diameter 3MM
  11. 2.3.5 Other
  12. 2.4 Nitinol Revascularization Device by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Clinic
  16. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Nitinol Revascularization Device Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Nitinol Revascularization Device Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Nitinol Revascularization Device Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Nitinol Revascularization Device Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Nitinol Revascularization Device Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Nitinol Revascularization Device, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Nitinol Revascularization Device, Product Type & Application
  8. 3.8 Global Manufacturers of Nitinol Revascularization Device, Established Date
  9. 3.9 Global Nitinol Revascularization Device Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Acandis GmbH
  2. 4.1.1 Acandis GmbH Company Information
  3. 4.1.2 Acandis GmbH Business Overview
  4. 4.1.3 Acandis GmbH Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Acandis GmbH Nitinol Revascularization Device Product Portfolio
  6. 4.1.5 Acandis GmbH Recent Developments
  7. 4.2 Balt Group
  8. 4.2.1 Balt Group Company Information
  9. 4.2.2 Balt Group Business Overview
  10. 4.2.3 Balt Group Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Balt Group Nitinol Revascularization Device Product Portfolio
  12. 4.2.5 Balt Group Recent Developments
  13. 4.3 Furukawa Techno Material
  14. 4.3.1 Furukawa Techno Material Company Information
  15. 4.3.2 Furukawa Techno Material Business Overview
  16. 4.3.3 Furukawa Techno Material Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Furukawa Techno Material Nitinol Revascularization Device Product Portfolio
  18. 4.3.5 Furukawa Techno Material Recent Developments
  19. 4.4 Johnson & Johnson MedTech
  20. 4.4.1 Johnson & Johnson MedTech Company Information
  21. 4.4.2 Johnson & Johnson MedTech Business Overview
  22. 4.4.3 Johnson & Johnson MedTech Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Johnson & Johnson MedTech Nitinol Revascularization Device Product Portfolio
  24. 4.4.5 Johnson & Johnson MedTech Recent Developments
  25. 4.5 Penumbra
  26. 4.5.1 Penumbra Company Information
  27. 4.5.2 Penumbra Business Overview
  28. 4.5.3 Penumbra Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Penumbra Nitinol Revascularization Device Product Portfolio
  30. 4.5.5 Penumbra Recent Developments
  31. 4.6 Rapid Medical
  32. 4.6.1 Rapid Medical Company Information
  33. 4.6.2 Rapid Medical Business Overview
  34. 4.6.3 Rapid Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Rapid Medical Nitinol Revascularization Device Product Portfolio
  36. 4.6.5 Rapid Medical Recent Developments
  37. 4.7 Stryker
  38. 4.7.1 Stryker Company Information
  39. 4.7.2 Stryker Business Overview
  40. 4.7.3 Stryker Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Stryker Nitinol Revascularization Device Product Portfolio
  42. 4.7.5 Stryker Recent Developments
  43. 4.8 Guichuangtongqiao Medical
  44. 4.8.1 Guichuangtongqiao Medical Company Information
  45. 4.8.2 Guichuangtongqiao Medical Business Overview
  46. 4.8.3 Guichuangtongqiao Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Guichuangtongqiao Medical Nitinol Revascularization Device Product Portfolio
  48. 4.8.5 Guichuangtongqiao Medical Recent Developments
  49. 4.9 Hemu Biotech
  50. 4.9.1 Hemu Biotech Company Information
  51. 4.9.2 Hemu Biotech Business Overview
  52. 4.9.3 Hemu Biotech Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hemu Biotech Nitinol Revascularization Device Product Portfolio
  54. 4.9.5 Hemu Biotech Recent Developments
  55. 4.10 Jianshi Medical
  56. 4.10.1 Jianshi Medical Company Information
  57. 4.10.2 Jianshi Medical Business Overview
  58. 4.10.3 Jianshi Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Jianshi Medical Nitinol Revascularization Device Product Portfolio
  60. 4.10.5 Jianshi Medical Recent Developments
  61. 4.11 Medtronic
  62. 4.11.1 Medtronic Company Information
  63. 4.11.2 Medtronic Business Overview
  64. 4.11.3 Medtronic Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Medtronic Nitinol Revascularization Device Product Portfolio
  66. 4.11.5 Medtronic Recent Developments
  67. 4.12 Sinoshenchang Medical
  68. 4.12.1 Sinoshenchang Medical Company Information
  69. 4.12.2 Sinoshenchang Medical Business Overview
  70. 4.12.3 Sinoshenchang Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Sinoshenchang Medical Nitinol Revascularization Device Product Portfolio
  72. 4.12.5 Sinoshenchang Medical Recent Developments
  73. 4.13 Suzhou Zhongtian Medical
  74. 4.13.1 Suzhou Zhongtian Medical Company Information
  75. 4.13.2 Suzhou Zhongtian Medical Business Overview
  76. 4.13.3 Suzhou Zhongtian Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Suzhou Zhongtian Medical Nitinol Revascularization Device Product Portfolio
  78. 4.13.5 Suzhou Zhongtian Medical Recent Developments
  79. 4.14 Micro-Port Shentong Medical
  80. 4.14.1 Micro-Port Shentong Medical Company Information
  81. 4.14.2 Micro-Port Shentong Medical Business Overview
  82. 4.14.3 Micro-Port Shentong Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Micro-Port Shentong Medical Nitinol Revascularization Device Product Portfolio
  84. 4.14.5 Micro-Port Shentong Medical Recent Developments
  85. 4.15 Xinkainuo Medical
  86. 4.15.1 Xinkainuo Medical Company Information
  87. 4.15.2 Xinkainuo Medical Business Overview
  88. 4.15.3 Xinkainuo Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Xinkainuo Medical Nitinol Revascularization Device Product Portfolio
  90. 4.15.5 Xinkainuo Medical Recent Developments
  91. 4.16 Xinwei Medical
  92. 4.16.1 Xinwei Medical Company Information
  93. 4.16.2 Xinwei Medical Business Overview
  94. 4.16.3 Xinwei Medical Nitinol Revascularization Device Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Xinwei Medical Nitinol Revascularization Device Product Portfolio
  96. 4.16.5 Xinwei Medical Recent Developments
5 Global Nitinol Revascularization Device Market Scenario by Region
  1. 5.1 Global Nitinol Revascularization Device Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Nitinol Revascularization Device Sales by Region: 2021-2032
  3. 5.2.1 Global Nitinol Revascularization Device Sales by Region: 2021-2026
  4. 5.2.2 Global Nitinol Revascularization Device Sales by Region: 2027-2032
  5. 5.3 Global Nitinol Revascularization Device Revenue by Region: 2021-2032
  6. 5.3.1 Global Nitinol Revascularization Device Revenue by Region: 2021-2026
  7. 5.3.2 Global Nitinol Revascularization Device Revenue by Region: 2027-2032
  8. 5.4 North America Nitinol Revascularization Device Market Facts & Figures by Country
  9. 5.4.1 North America Nitinol Revascularization Device Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Nitinol Revascularization Device Sales by Country (2021-2032)
  11. 5.4.3 North America Nitinol Revascularization Device Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Nitinol Revascularization Device Market Facts & Figures by Country
  16. 5.5.1 Europe Nitinol Revascularization Device Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Nitinol Revascularization Device Sales by Country (2021-2032)
  18. 5.5.3 Europe Nitinol Revascularization Device Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Nitinol Revascularization Device Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Nitinol Revascularization Device Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Nitinol Revascularization Device Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Nitinol Revascularization Device Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Nitinol Revascularization Device Market Facts & Figures by Country
  41. 5.7.1 South America Nitinol Revascularization Device Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Nitinol Revascularization Device Sales by Country (2021-2032)
  43. 5.7.3 South America Nitinol Revascularization Device Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Nitinol Revascularization Device Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Nitinol Revascularization Device Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Nitinol Revascularization Device Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Nitinol Revascularization Device Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Nitinol Revascularization Device Sales by Type (2021-2032)
  2. 6.1.1 Global Nitinol Revascularization Device Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Nitinol Revascularization Device Sales Market Share by Type (2021-2032)
  4. 6.2 Global Nitinol Revascularization Device Revenue by Type (2021-2032)
  5. 6.2.1 Global Nitinol Revascularization Device Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Nitinol Revascularization Device Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Nitinol Revascularization Device Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Nitinol Revascularization Device Sales by Application (2021-2032)
  2. 7.1.1 Global Nitinol Revascularization Device Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Nitinol Revascularization Device Sales Market Share by Application (2021-2032)
  4. 7.2 Global Nitinol Revascularization Device Revenue by Application (2021-2032)
  5. 7.2.1 Global Nitinol Revascularization Device Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Nitinol Revascularization Device Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Nitinol Revascularization Device Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Nitinol Revascularization Device Value Chain Analysis
  2. 8.1.1 Nitinol Revascularization Device Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Nitinol Revascularization Device Production Mode & Process
  5. 8.2 Nitinol Revascularization Device Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Nitinol Revascularization Device Distributors
  8. 8.2.3 Nitinol Revascularization Device Customers
9 Global Nitinol Revascularization Device Analyzing Market Dynamics
  1. 9.1 Nitinol Revascularization Device Industry Trends
  2. 9.2 Nitinol Revascularization Device Industry Drivers
  3. 9.3 Nitinol Revascularization Device Industry Opportunities and Challenges
  4. 9.4 Nitinol Revascularization Device Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst